For most people, the first meeting with an oncologist happens only after something has already gone wrong.

The introduction happens in an exam room, often on one of the worst days of a person’s life. A scan has revealed something concerning. A biopsy has confirmed a diagnosis. Questions outnumber answers, and urgency has replaced choice.

That sequence feels normal because it is how modern cancer care has been built. Oncology has historically been designed to diagnose, stage, and treat cancer after it has already developed.

But there is an important question few people stop to ask:

Why does our relationship with an oncologist begin only after cancer becomes a possibility?

For heart disease, we do not wait for a heart attack before involving a cardiologist. For diabetes, we monitor risk years before complications develop. Across medicine, specialists are increasingly focused on prevention and early intervention.

Cancer has largely remained the exception.

PreOncology is a medical oncology practice dedicated to cancer risk management and early detection. The practice exists to change that timeline.

Rethinking When Oncology Begins

Most people think of oncology as a specialty reserved for treatment.

In reality, medical oncologists are uniquely trained to understand how cancers develop, how risk changes over time, which surveillance strategies are most appropriate, and when a finding deserves immediate attention versus careful observation.

Those are valuable perspectives long before someone is diagnosed with cancer.

Yet under today’s healthcare model, most people never benefit from that expertise until they are already facing one of the most stressful moments of their lives.

There is an opportunity to bring oncology expertise upstream, while there is still time to reduce uncertainty, personalize surveillance strategies, and potentially change the outcome altogether.

Why One-Size-Fits-All Screening Has Limits

Current cancer screening guidelines have saved countless lives and remain essential. But they were designed for populations, not individuals.

Two healthy 48-year-olds may receive the same screening recommendations despite having dramatically different genetics, family histories, environmental exposures, and biological risk factors.

Population guidelines must simplify risk in order to work at scale. Individuals are rarely that simple. Genetics, inherited predisposition, lifestyle, environmental exposures, prior medical history, and emerging biological signals all contribute to a person’s unique risk profile.

That creates an opportunity to think differently about cancer risk management. Rather than relying solely on generalized screening schedules, care can begin with a personalized understanding of an individual’s risk and evolve over time as new clinical information becomes available.

Cancer Biology Begins Before Cancer Can Be Seen

Most people think cancer begins when a tumor appears on a scan. In reality, the biological processes that lead to cancer often begin years earlier.

Conventional oncology staging begins at Stage 0, when pathology is already localized and a lesion is visible. But cancer does not begin there. Converging evidence from circulating tumor DNA, radiomics, immune profiling, and multi-omic biomarkers demonstrates that malignant biology is active well before any lesion can be seen.

PreOncology defines that window as Stage Alpha: a biologically active, preclinical state in which cancer is detectable, but no tumor has yet localized. It is the earliest point at which interception is possible, and where early detection and individualized surveillance have the greatest potential to alter the outcome.

What Proactive Oncology Access Looks Like

The PreOncology Program uses whole genome sequencing, advanced cancer risk modeling, family history, lifestyle factors, and clinical data to personalize cancer risk management and early detection.

The program is initiated through primary care physicians and overseen directly by board-certified medical oncologists.

Every member begins with the Stage Alpha Assessment, a three-part process that establishes each individual’s cancer risk profile and delivers an oncologist-prescribed, guideline-based surveillance protocol to the physician for review. From there, members continue guideline-based screening with their primary care physician, with risk reassessed regularly and their genomic data reinterpreted as the science advances.

When risk, surveillance needs, or a physician’s guidance warrant it, a member and their physician may decide that PreOncology should take a more active role, coordinating directly with the physician to order and manage a personalized surveillance plan. This can include risk-specific blood indices, tumor markers, MCED tests, ctDNA, and imaging such as whole-body MRI, ordered and coordinated by PreOncology as clinically indicated. Testing performed under the plan is billed separately at actual cost.

All recommended testing is coordinated as part of the program.

What Changes With PreOncology

Under the traditional population-based care model, an individual’s connection to oncology begins at the point of crisis. Decisions are made under time pressure, often without the benefit of a prevention history or a baseline understanding of that individual’s biology. When cancer care is moved upstream, that relationship begins years earlier, when there is still time to act with clarity rather than urgency.

For members, this also changes what oversight looks like when something does need a closer look. If a result raises a question, it is reviewed by the Signal Board, a team of board-certified medical oncologists who evaluate the finding and provide a clear path forward to the member and their primary care physician.

Deciding If a Cancer Risk Management and Early Detection Program Is Right for You

That kind of standard, oncology expertise present before it is needed rather than summoned only once it is, is not something most people have access to today. Deciding whether it is right for you comes down to a simpler question: do you want an ongoing, personalized understanding of your cancer risk, rather than relying solely on standard, population-based screening?

The PreOncology Program is physician-supervised and works alongside your existing care team. Routine screenings such as mammograms, colonoscopies, and other guideline-based recommendations remain an essential part of your care.

To learn more about the PreOncology Program, download the member overview brochure.

If you are interested in joining the program, fill out the form and we will contact your primary care physician on your behalf to discuss the program in more detail.

The best time to have an oncologist is before you have cancer. PreOncology was created to make that possible.